ELI LILLY & Co (LLY) revenue & profit
ELI LILLY & Co (LLY): revenue $65.2B, net income $20.6B in 2025; latest quarter +47.7% year over year. From SEC filings.
$65.2BRevenue 2025
TickerLLY (NYSE)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$65.2B
Net income 2025$20.6B
Net margin31.7%
Annual revenue growth+44.7%
Latest quarter (2026 Q2) · Revenue$23B
vs. same quarter last year+47.7%
Latest quarter · Net income$7.1B
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $28.5B | $6.2B | |
| 2023 | $34.1B | $5.2B | |
| 2024 | $45B | $10.6B | |
| 2025 | $65.2B | $20.6B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.